
Keywords: 0.5q4; 0.5 mg intravitreal aflibercept injection every 4 weeks; 2q4; 2 mg intravitreal aflibercept injection every 4 weeks; 2q8; 2 mg intravitreal aflibercept injection every 8 weeks after 3 initial monthly injections; ANCHOR; Anti-VEGF Antibody for the T